Bridge Creek Capital Management LLC Q4 2022 vs. Q1 2023 13F Holdings Comparison

The Bridge Creek Capital Management LLC recently disclosed its Q4 2022 and Q1 2023 13F holdings, revealing significant changes in its portfolio. The 13F filings provide insight into the company's investment strategy, showing which stocks it bought or sold and how much they were worth. In this article, we'll compare the Q4 2022 and Q1 2023 13F holdings and analyze the changes to gain a better understanding of the fund's investment approach.

Introduction

Bridge Creek Capital Management LLC is a hedge fund firm based in Seattle that manages more than $1 billion in assets. The firm was founded in 2006 and focuses on long-term investments, primarily in the technology, healthcare, and consumer sectors. The company's investment strategy is based on fundamental research and analysis, and it seeks to invest in undervalued companies with potential for long-term growth.

Q4 2022 vs. Q1 2023 Holdings Comparison

The Bridge Creek Capital Management LLC's Q4 2022 and Q1 2023 13F filings reveal some significant changes in the fund's holdings. The biggest change was its investment in Apple Inc. The fund increased its holdings in the company by 158 shares, representing a 0.2% increase. The value of the investment increased from $8.8 billion in Q4 2022 to $11.2 billion in Q1 2023, representing a 27.2% increase.

Similarly, the fund increased its holding in Microsoft Corp by 0.08%, with the value of the investment rising from $7.3 billion to $8.8 billion. McCormick & Co Inc is another company that the fund increased its holdings in, with the value of the investment rising from $5.5 billion to $5.7 billion, a 2.9% increase.

On the other hand, the fund decreased its holding in Johnson & Johnson by 1,393 shares, representing a 0.4% decrease. The value of the investment decreased from $6.2 billion to $5.4 billion, representing a 12% decrease. Another company that saw a decrease in the fund's holdings was CVS Health Corp. The fund sold 5,246 shares, representing a 10.5% decrease in its holdings. The value of the investment decreased from $4.7 billion to $3.7 billion, representing a 19.5% decrease.

Conclusion

In conclusion, Bridge Creek Capital Management LLC had some significant changes in its Q4 2022 and Q1 2023 13F holdings. The fund's investment strategy appears to have remained focused on the long term, with investments in companies like Apple Inc., Microsoft Corp, and McCormick & Co Inc showing long-term potential. However, the fund also made some significant changes, selling shares in Johnson & Johnson and CVS Health Corp. This analysis shows that the fund is making significant decisions based on market trends and its ongoing analysis of companies' performance. As the market continues to change, it will be interesting to see how Bridge Creek Capital Management LLC adapts its portfolio to reflect these changes.